Drug Prices In Us
- All
- News
- Videos
-
With 2024 In Mind, Joe Biden's Big Move To Lower Drug Prices
US President Joe Biden, who is campaigning for reelection with a heavy focus on easing voters' financial woes, on Tuesday launched a bid to lower the cost of certain prescription drugs -- a move Big Pharma pledged to continue battling in court.
-
Lupin Gains On Receiving US FDA Nod To Launch Drug For Onychomycosis
Lupin received approval to launch Tavaborole Topical Solution, 5 per cent in United States (US) from the United States Food and Drug Administration (FDA).
-
Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US
The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.
-
Trump Says He Has Signed New Executive Order To Lower Drug Prices
US President Donald Trump said on Sunday he had signed a new executive order aimed at lowering drug prices in the United States by linking them to those of other nations.
-
US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID
Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its prior recommendation of around $4,500.
-
Why Shares Of This Bengaluru-Based Drug Maker Plunged Over 8% Today
US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records.
-
Donald Trump Promises To Reduce US Drug Prices To World's Lowest
US President Donald Trump on Friday said his administration is working on an executive order to reduce US drug prices to match the lowest in the world.
-
Lawsuit Against Aurobindo Pharma, Other Drug Makers Filed In US
Aurobindo said it does not anticipate that these matters will have a material impact on the its operations or business results.
-
Aurobindo Pharma Shares Jump 6% After Drug Maker Announces $900-Million US Acquisition
Aurobindo Pharma share price jumped more than 6 per cent in intraday trade with large volumes after the announcement. Aurobindo Pharma said it will acquire the dermatology and oral solids businesses from Sandoz Inc, USA, a unit of Swiss pharmaceutical company Novartis. Aurobindo Pharma said the deal worth $900 million was expected to close in 2019...
-
Trump Says Drugmaker Pfizer Should Be "Ashamed" For Drug Price Hikes
US President Donald Trump on Monday took aim at Pfizer Inc and other US drugmakers after they raised prices on some of their medicines on July 1, saying his administration would act in response.
-
Donald Trump's New Drug Price Promise May Have Negative Impact On India
US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy that could have negative implications for India.
-
US President Donald Trump Promises Action On Drug Prices That May Impact India
US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy that could have implications for India.
-
Sun Pharma Stock Slip 4% As Quarterly Earnings Decline
The drug major saw a 14 percent dip in consolidated net profit in Q4 due to pricing pressure in the US market.
-
Indian Drugmakers Face Squeeze In US Healthcare Market
Consolidation among U.S. drugs distributors and a federal investigation into drug pricing have also reduced the pricing power of drugsmakers.
-
Pharma Stocks Hit After Trump's 'Getting Away With Murder' Comment
Dr Reddy's Laboratories, Sun Pharmaceutical Industries and Lupin were the most hit, suffering losses of up to 3 per cent.
-
With 2024 In Mind, Joe Biden's Big Move To Lower Drug Prices
US President Joe Biden, who is campaigning for reelection with a heavy focus on easing voters' financial woes, on Tuesday launched a bid to lower the cost of certain prescription drugs -- a move Big Pharma pledged to continue battling in court.
-
Lupin Gains On Receiving US FDA Nod To Launch Drug For Onychomycosis
Lupin received approval to launch Tavaborole Topical Solution, 5 per cent in United States (US) from the United States Food and Drug Administration (FDA).
-
Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US
The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.
-
Trump Says He Has Signed New Executive Order To Lower Drug Prices
US President Donald Trump said on Sunday he had signed a new executive order aimed at lowering drug prices in the United States by linking them to those of other nations.
-
US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID
Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its prior recommendation of around $4,500.
-
Why Shares Of This Bengaluru-Based Drug Maker Plunged Over 8% Today
US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records.
-
Donald Trump Promises To Reduce US Drug Prices To World's Lowest
US President Donald Trump on Friday said his administration is working on an executive order to reduce US drug prices to match the lowest in the world.
-
Lawsuit Against Aurobindo Pharma, Other Drug Makers Filed In US
Aurobindo said it does not anticipate that these matters will have a material impact on the its operations or business results.
-
Aurobindo Pharma Shares Jump 6% After Drug Maker Announces $900-Million US Acquisition
Aurobindo Pharma share price jumped more than 6 per cent in intraday trade with large volumes after the announcement. Aurobindo Pharma said it will acquire the dermatology and oral solids businesses from Sandoz Inc, USA, a unit of Swiss pharmaceutical company Novartis. Aurobindo Pharma said the deal worth $900 million was expected to close in 2019...
-
Trump Says Drugmaker Pfizer Should Be "Ashamed" For Drug Price Hikes
US President Donald Trump on Monday took aim at Pfizer Inc and other US drugmakers after they raised prices on some of their medicines on July 1, saying his administration would act in response.
-
Donald Trump's New Drug Price Promise May Have Negative Impact On India
US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy that could have negative implications for India.
-
US President Donald Trump Promises Action On Drug Prices That May Impact India
US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy that could have implications for India.
-
Sun Pharma Stock Slip 4% As Quarterly Earnings Decline
The drug major saw a 14 percent dip in consolidated net profit in Q4 due to pricing pressure in the US market.
-
Indian Drugmakers Face Squeeze In US Healthcare Market
Consolidation among U.S. drugs distributors and a federal investigation into drug pricing have also reduced the pricing power of drugsmakers.
-
Pharma Stocks Hit After Trump's 'Getting Away With Murder' Comment
Dr Reddy's Laboratories, Sun Pharmaceutical Industries and Lupin were the most hit, suffering losses of up to 3 per cent.
